Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:35 pm Unchanged | 2023-02-14 | 13G | Concert Pharmaceuticals, Inc. CNCE | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:35 pm Unchanged | 2023-02-14 | 13G | Prometheus Biosciences, Inc. RXDX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:33 pm Unchanged | 2023-02-14 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:33 pm Unchanged | 2023-02-14 | 13G | Tarsus Pharmaceuticals, Inc. TARS | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:33 pm Unchanged | 2023-02-14 | 13G | IsoPlexis Corporation ISO | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:33 pm Unchanged | 2023-02-14 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:33 pm Unchanged | 2023-02-14 | 13G | IVERIC bio, Inc. ISEE | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:33 pm Unchanged | 2023-02-14 | 13G | Aldeyra Therapeutics, Inc. ALDX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:32 pm Unchanged | 2023-02-14 | 13G | Iovance Biotherapeutics, Inc. IOVA | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:32 pm Unchanged | 2023-02-14 | 13G | BELLUS Health Inc. BLU | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:31 pm Unchanged | 2023-02-14 | 13G | Zymeworks Inc. ZYME | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:31 pm Unchanged | 2023-02-14 | 13G | enVVeno Medical Corporation NVNO | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:31 pm Unchanged | 2023-02-14 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:31 pm Unchanged | 2023-02-14 | 13G | RAPT Therapeutics, Inc. RAPT | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:31 pm Unchanged | 2023-02-14 | 13G | Arcellx, Inc. ACLX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:31 pm Unchanged | 2023-02-14 | 13G | ADMA Biologics, Inc. ADMA | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:31 pm Unchanged | 2023-02-14 | 13G | Agile Therapeutics, Inc. AGRX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:31 pm Unchanged | 2023-02-14 | 13G | Albireo Pharma, Inc. ALBO | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:31 pm Unchanged | 2023-02-14 | 13G | Veru Inc. VERU | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:31 pm Unchanged | 2023-02-14 | 13G | SpringWorks Therapeutics, Inc. SWTX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |